• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AOMORI OLYMPUS CO., LTD. INJECTOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AOMORI OLYMPUS CO., LTD. INJECTOR Back to Search Results
Model Number NM-4L-1
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Hemorrhage/Bleeding (1888)
Event Date 02/01/2023
Event Type  Injury  
Manufacturer Narrative
The suspect device has not been returned to olympus for evaluation.The investigation is in process.Once the investigation has been completed, a supplemental report will be submitted with device evaluation results.
 
Event Description
Olympus reviewed the following literature titled "endoscopic submucosal dissection for large duodenal laterally spreading lesions is feasible: a multi-center retrospective study".This multicentric retrospective study sought to assess the effect and safety of esd for large laterally spreading lesions located in the descending duodenum based on multi-center experiences.A total of 51 patients were included.The average procedure time for en bloc resection ranging from 20 to 117 min (median: 45.5 min).Two patients experienced delayed bleeding 3 days after esd and 2 other patients were diagnosed with delayed perforation.All the patients were closely followed up for a median period of 16 months (range 7 to 29 months), and there were no deaths.No residual tumor and local recurrence occurred during follow-up.Esd for laterally spreading lesions of the descending duodenum is a feasible therapeutic procedure and can achieve a favorable en bloc resection rate.Type of adverse events/number of patients: delayed bleeding: case 1; delayed bleeding: case 2; delayed perforation (postoperative fever, mild abdominal pain): case 3; delayed perforation (fever, severe abdominal pain, diffuse peritonitis): case 4.This literature article requires 28 reports.The related patient identifiers are as follows: 1.(b)(6) /case1(female, 64)/kd-620lr; 2.(b)(6) /case1(female, 64)/kd-611l; 3.(b)(6) /case1(female, 64)/fg-8u-1; 4.(b)(6) /case1(female, 64)/nm-4l-1; 5.(b)(6) /case1(female, 64)/fd-410lr; 6.(b)(6) /case1(female, 64)/gif-h260; 7.(b)(6) /case1(female, 64)/maj-339; 8.(b)(6) /case2(male, 63)/kd-620lr; 9.(b)(6) /case2(male, 63)/kd-611l; 10.(b)(6) /case2(male, 63)/fg-8u-1; 11.(b)(6) /case2(male, 63)/nm-4l-1; 12.(b)(6) /case2(male, 63)/fd-410lr; 13.(b)(6) /case2(male, 63)/gif-h260; 14.(b)(6) /case2(male, 63)/maj-339; 15.(b)(6) /case3(male, 57)/kd-620lr; 16.(b)(6) /case3(male, 57)/kd-611l; 17.(b)(6) /case3(male, 57)/fg-8u-1; 18.(b)(6) /case3(male, 57)/nm-4l-1; 19.(b)(6) /case3(male, 57)/fd-410lr; 20.(b)(6) /case3(male, 57)/gif-h260; 21.(b)(6) /case3(male, 57)/maj-339; 22.(b)(6) /case4(female, 61)/kd-620lr; 23.(b)(6) /case4(female, 61)/kd-611l; 24.(b)(6) /case4(female, 61)/fg-8u-1; 25.(b)(6) /case4(female, 61)/nm-4l-1; 26.(b)(6) /case4(female, 61)/fd-410lr; 27.(b)(6) /case4(female, 61)/gif-h260; 28.(b)(6) /case4(female, 61)/maj-339.This medwatch report is for patient identifier (b)(6).There is no report of any olympus device malfunction in any procedure described in this study.
 
Manufacturer Narrative
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation and follow-up from the author.The device history record was unable to be reviewed for this device since the serial and/or lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the relationship between the device and the adverse events cannot be confirmed.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.Therefore, the root cause cannot be determined.Olympus will continue to monitor field performance for this device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INJECTOR
Type of Device
INJECTOR
Manufacturer (Section D)
AOMORI OLYMPUS CO., LTD.
2-248-1 okkonoki
kuroishi-shi, aomori 036-0 357
JA  036-0357
Manufacturer (Section G)
AOMORI OLYMPUS CO., LTD.
2-248-1 okkonoki
kuroishi-shi, aomori
Manufacturer Contact
todd brill
800 west park drive
westborough, MA 01581
5082077661
MDR Report Key16721453
MDR Text Key313122021
Report Number9614641-2023-00489
Device Sequence Number1
Product Code FBK
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K011484
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Study,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/10/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/11/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberNM-4L-1
Device Lot NumberUNKNOWN(LITERATURE)
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received04/11/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age64 YR
Patient SexFemale
-
-